CytomX Therapeutics
CTMX
NASDAQ
IPO2015
about CTMX
CytomX Therapeutics is a biopharmaceutical company dedicated to developing innovative cancer therapies using its Probody platform, which enables targeted and effective treatments for various cancers.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.92 | $8.21 | $6.04 | $792.96M | 108.98M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | 189.96 | -264.43% | -238.62% | 0% |